Adverse effects of xenogenic scaffolding in the context of a randomized double-blind placebo-controlled study for repairing full-thickness rotator cuff tears

Table 2 Visual representation of all outcomes included in the study

	Sex	Age	Shoulder involved	Preoperative					Postoperative
				Constant		Patte’s score	Thomazeau’s score	VAS	Constant*		Patte’s Score	Thomazeau’s Score	VAS	Recurrent tear	Repair Integrity	AEs
				Contralateral shoulder	Injured shoulder	Patte’s score	Thomazeau’s score	VAS	Contralateral shoulder	Injured shoulder	Patte’s Score	Thomazeau’s Score	VAS	Recurrent tear	Repair Integrity	AEs
Control group
HCSC-1	Male	65	LS	93	60	1	1	8	91	33.5	1	1	1	Yes	No	No
HCSC-2	Mujer	66	RS	96	56	1	1	8	92	71	2	2	2	Yes	No	Yes
HCSC-13	Male	62	RS	75	48	1	1	9	70	66	2	2	4	Yes	No	No
HCSC-14	Female	57	RS	81	55	1	1	8	84	80	1	1	2	No	Yes	No
HCSC-15	Female	59	RS	80	37	2	2	8	80	77	1	1	2	No	Yes	No
Treatment group
HCSC-3	Male	61	RS	65	30	3	3	9	87	63	3	3	6	Yes	No	No
HCSC-4	Male	62	RS	79	36	2	2	9	79	43	3	3	8	Yes	No	Yes
HCSC-5	Male	48	RS	94	35	2	2	8	96	62	3	3	3	Yes	No	Yes
HCSC-6	Male	60	RS	91	53	2	1	8	91	86	2	2	1	Yes	No	No
HCSC-7	Male	49	RS	89	63	1	1	7	98	87	2	2	1	No	Yes	No
HCSC-10	Female	60	RS	87	48	1	1	8	93	74	2	2	2	Yes	No	Yes
HCSC-11	Male	49	RS	89	48	1	1	8	90	79	1	1	1	No	Yes	No
HCSC-12	Female	65	RS	80	43	1	1	8	80	82	1	1	1	No	Yes	No

AEs adverse events, VAS visual analogue scale
* Statistically significant recovery between injured and contralateral shoulder in the treatment group. P = 0.0073

ISSN: 1745-6215